Cargando…
Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus
Comment on the article of Usui et al. Retrospective cohort study of obese patients with type 2 diabetes mellitus (n = 69) demonstrates that the glucose‐lowering effect of liraglutide as add on therapy to insulin relies on the remaining beta‐cell function in type 2 diabetes. Shorter disease duration...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031510/ https://www.ncbi.nlm.nih.gov/pubmed/29974671 http://dx.doi.org/10.1111/jdi.12857 |